Effect of Bifidobacterium bifidum BF-1 on gastric protection and mucin production in an acute gastric injury rat model

Journal of Dairy Science

Volumn 96, Issue 2, 2013, Pages 832-837

  Gomi, A ^a   Harima Mizusawa, N ^a   Shibahara Sone, H ^a   Kano, M ^a   Miyazaki, K ^a   Ishikawa, F ^a  

^a YAKULT CENTRAL INSTITUTE FOR MICROBIOLOGICAL RESEARCH   (Japan)

Author keywords

Bifidobacterium bifidum BF 1; Gastroprotective effect; Mucin; Probiotics

Indexed keywords

ALCOHOL; MUC5AC PROTEIN, RAT; MUCIN; MUCIN 5AC; PROBIOTIC AGENT;

ANIMAL; ARTICLE; BIFIDOBACTERIUM; BIOSYNTHESIS; DAIRY PRODUCT; DISEASE MODEL; DRUG EFFECT; MALE; METABOLISM; MICROBIOLOGY; RAT; SPRAGUE DAWLEY RAT; STOMACH; STOMACH DISEASE;

ANIMALS; BIFIDOBACTERIUM; CULTURED MILK PRODUCTS; DISEASE MODELS, ANIMAL; ETHANOL; MALE; MUCIN 5AC; MUCINS; PROBIOTICS; RATS; RATS, SPRAGUE-DAWLEY; STOMACH; STOMACH DISEASES;

ANIMALIA; BIFIDOBACTERIUM BIFIDUM; HELICOBACTER PYLORI; RATTUS; STREPTOCOCCUS THERMOPHILUS;

EID: 84872684721     PISSN: 00220302     EISSN: 15253198     Source Type: Journal    
DOI: 10.3168/jds.2012-5950     Document Type: Article

References (23)

1. Allen A., Garner A. Mucus and bicarbonate secretion in the stomach and their possible role in mucosal protection. Gut 1980, 21:249-262.
2. Boyd E.J.S., Wormsley K.G. Etiology and pathology of peptic ulcer. Bockus Gastroenterology 1985, 2:1013-1059. W. B. Sanders Co, Philadelphia, PA. J.E. Berk (Ed.).
3. Cain A.M., Karpa K.D. Clinical utility of probiotics in inflammatory bowel disease. Altern. Ther. Health Med 2011, 17:72-79.
4. FAO/WHO (Food and Agriculture Organization of the United Nations/World Health Organization). 2001. Health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. Report of a joint FAO/WHO expert consultation. FAO, Rome, Italy and WHO, Geneva, Switzerland.
5. Ishihara K., Hotta K. Comparison of the mucus glycoproteins present in the different layers of rat gastric mucosa. Comp. Biochem. Physiol. B 1993, 104:315-319.
6. Isolauri E., Sütas Y., Kankaanpää P., Arvilommi H., Salminen S. Probiotics: Effects on immunity. Am. J. Clin. Nutr 2001, 73:444S-450S.
7. Kauffman G.L. Gastric mucus and bicarbonate secretion in relation to mucosal protection. J. Clin. Gastroenterol 1981, 3:45-50.
8. Kawauchi S., Mimaki H., Kitazaki H., Takeuchi K. Effect of dilute acetic acid on rat gastric mucosa following acute and chronic administration. Jpn. Pharmacol. Therapeut 2000, 28:473-480.
9. Matsuki T., Watanabe K., Fujimoto J., Kado Y., Takada T., Matsumoto K., Tanaka R. Quantitative PCR with 16S rRNA-gene-targeted species-specific primers for analysis of human intestinal bifidobacteria. Appl. Environ. Microbiol 2004, 70:167-173.
10. Miki K., Urita Y., Ishikawa F., Iino T., Shibahara-Sone H., Akahoshi R., Mizusawa S., Nose A., Nozaki D., Hirano K., Nonaka C., Yokokura T. Effect of Bifidobacterium bifidum fermented milk on Helicobacter pylori and serum pepsinogen levels in humans. J. Dairy Sci 2007, 90:2630-2640.
11. Miyazaki K., Matsuzaki T. Health properties of milk fermented with Lactobacillus casei strain Shirota (LcS). Handbook of Fermented Functional Foods 2008, 165-172. CRC Press, Boca Raton, FL. 2nd. R.F. Edward (Ed.).
12. Nagaoka M., Hashimoto S., Watanabe T., Yokokura T., Mori Y. Anti-ulcer effects of lactic acid bacteria and their cell wall polysaccharides. Biol. Pharm. Bull 1994, 17:1012-1017.
13. Neutra M.R., Forstner J.E. Gastrointestinal mucus: Synthesis, secretion, and function. Physiology of the Gastrointestinal Tract 1987, 2:975-1009. Raven Press, New York, NY. L.R. Johnson (Ed.).
14. Newton J.L. The adherent gastric antral and duodenal mucus gel layer thins with advancing age in subjects infected with Helicobacter pylori. Gerontology 2000, 46:153-157.
15. Picard C., Fioramonti J., Francois A., Robinson T., Neant F., Matuchansky C. Bifidobacteria as probiotic agents-Physiological effects and clinical benefits. Aliment. Pharmacol. Ther 2005, 22:495-512.
16. Reid G., Hammond J.A. Probiotics. Some evidence of their effectiveness. Can. Fam. Physician 2005, 51:1487-1493.
17. Schwarz K. über penetrierende Magen- und Jejunalgeschwure. Beitr. Klin. Chir 1910, 67:96-128.
18. Shimakawa Y., Matsubara S., Yuki N., Ikeda M., Ishikawa F. Evaluation of Bifidobacterium breve strain Yakult-fermented soymilk as a probiotic food. Int. J. Food Microbiol 2003, 81:131-136.
19. Shirasawa Y., Shibahara-Sone H., Iino T., Ishikawa F. Bifidobacterium bifidum BF-1 suppresses Helicobacter pylori-induced genes in human epithelial cells. J. Dairy Sci 2010, 93:4526-4534.
20. Shorrock C.J., Rees W.D.W. Mechanisms of gastric damage by non-steroidal anti-inflammatory drugs. Scand. J. Rheumatol. Suppl 1989, 78:5-11. discussion 30-32.
21. Watanabe K., Miyake T., Matsuki T., Oyaizu H. The use of 16SrRNA gene sequences to identify Lactobacillus species in fermented daily products. Molecular Ecology of the Intestinal Flora 1998, 129-154. Japan Scientific Societies Press, Tokyo, Japan. T. Mitsuoka (Ed.).
22. Yakult Central Institute for Microbiological Research. 2012. Advances in the Science of Bifidobacterium Yakult Strains-Intestinal Microbiota and Human Health. Yakult Honsha Co. Ltd., Tokyo, Japan.
23. Yamamoto Y., Sakurabayashi S., Abe K., Sezai S., Hirano M., Oka H. Anti-ulcer effect of Bifidobacterium bifidum YIT 4007. Jpn. Pharmacol. Therapeut 1994, 22:4743-4746. (In Japanese.).